Click here for coronavirus updates

Moderna to price coronavirus vaccine between $32 and $37 per dose


One of the companies working on a coronavirus vaccine said Wednesday that it’s on track to finish enrollment for a phase three study before October.

Moderna also said it plans to make the vaccine affordable below $40 per dose for most customers.

This as all drug companies are being closely watched to see what they plan to charge for COVID-19 treatments.

In June, Biotech Gilead Sciences revealed that its remdesivir drug would cost more than $500 a vial for people with private health insurance.

Moderna is just one of several U.S. drug companies racing to come up with a successful vaccine. Novavax and Pfizer have also had promising vaccine results so far.


Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Download the KSN News App and stay up-to-date wherever you are. You can even watch KSN News live for free!
Click here to get the app
Get it in the App store
Get it in the Google Play store

3 Day Forecast

KSN Storm Track 3 Weather

Trending Stories